|
Institutional Biosafety Committee
|
|
The major responsibilities of this committee include:
- Advising the vice chancellor for Business Affairs on all matters relating to the safe use of hazardous biological materials and organisms
- Establishing, monitoring, and enforcing policies
and procedures for biohazardous materials and/or recombinant DNA, including gene transfer clinical trials
- Reviewing and approving use of biohazardous materials and/or recombinant DNA
- Imposing disciplinary measures for willful or negligent violation of UCSD's established biosafety practices and procedures
Read the complete committee charge.
|
Ex officio |
Departments |
|
Benedict, Steve |
Director, Environment, Health & Safety |
|
Clark, Mark |
Department Safety Officer, SOM/ DOM |
|
Durand, Deborah |
Vivarium Safety Officer |
|
Hull, Teresa |
Committee Secretary |
| Kent, Carol |
Biological Safety Specialist |
| Kowalewsky, Steve |
Biological Safety Consultant |
|
Mullen, Seth |
Biological Safety Specialist |
|
Richter, Phil |
Veterinarian Representative (Voting) |
|
Siddiqui, Aleem (Chair) |
Department of Medicine (Voting) |
|
Smith, Ken |
Research Safety Manager |
|
Springer, Wayne |
Veterans Affairs Biosafety Committee |
|
Torriani, Francesca |
Medical Director – Infection Prevention/ Clinical Epidemiology Unit |
|
Wong, Brenda |
Biological Safety Officer (Voting) |
|
Appointed |
Departments |
|
Banta, Brent |
Community Representative |
| Corbeil, Lynette |
School of Medicine/Infectious Agents/ Recombinant DNA |
|
Crawford, Nigel |
Plant Expert |
|
Friedmann, Theodore |
Human Gene Therapy Clinical Trials Rep |
|
Levine, Fred |
Recombinant DNA/ Gene Therapy Representative |
|
Peter, Christopher |
Community Representative |
| Pillus, Lorraine |
General Campus Faculty Representative |
|
Ramras, Donald |
Community Representative |
|
Schooley, Robert |
School of Medicine Faculty Representative |
| Vacant |
Recombinant DNA/ Infectious Disease Representative |
|
Vacant |
Staff Representative |
Charge to committee:
The IBC is advisory to the chancellor through the vice chancellor for Business Affairs on all matters relating to the safe use of hazardous biological materials and organisms. It is the committee's responsibility to establish, monitor, and enforce policies and procedures which meet or exceed applicable norms or regulations for biohazardous materials and/or recombinant DNA, including gene transfer clinical trials. Any use of biohazardous materials and/or recombinant DNA must be reviewed and approved by the committee (or the Biological Safety Officer operating within guidelines established by the committee).
The committee has the authority to impose disciplinary measures in cases where there is willful or negligent violation of UCSD's established biosafety practices and procedures. The sanctions are subject to review and/or modification by the chancellor. The committee shall maintain diverse membership representing the community and a variety of university interests. Non-committee faculty or staff with a particular expertise will be asked to advise the committee when the need arises.
Changes or updates? Contact Rachel Jensen, (858) 534-7951.
|
At Your Service Online
